Prostate Cancer Combination Therapy, Abiraterone Acetate, Niraparib
Summary
USPTO published patent application US20260097048A1 for a combination therapy of abiraterone acetate and niraparib for treating prostate cancer. The application was filed on December 11, 2025, by inventors Thomas Ronald A. Quinten and colleagues, covering free-dose and fixed-dose combinations and methods of treatment.
What changed
USPTO published patent application US20260097048A1 for a combination therapy of abiraterone acetate and niraparib for treating prostate cancer. The application covers free-dose and fixed-dose combinations and methods of use for prostate cancer treatment. Inventors include Thomas Ronald A. Quinten, Urbain Alfons C. Delaet, Philip Erna H. Heyns, and others.\n\nPharmaceutical manufacturers and oncology researchers should monitor published patent applications as they may indicate future competitive developments and potential freedom-to-operate considerations. Patent applications establish priority rights and inform the public of claimed subject matter.
What to do next
- Monitor for updates
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE ACETATE AND NIRAPARIB
Application US20260097048A1 Kind: A1 Apr 09, 2026
Inventors
Thomas Ronald A. QUINTEN, Urbain Alfons C. DELAET, Philip Erna H. HEYNS, Tatiana MARCOZZI, Johny BERTELS, Katrien LUYTEN, Kaustubh Ramesh TAMBWEKAR, Angela LOPEZ-GITLITZ, Paul J. A. HARTMAN KOK
Abstract
The present disclosure relates to a combination of abiraterone acetate and niraparib, free-dose and fixed-dose combinations of abiraterone acetate and niraparib, and methods of treatment of prostate cancer with said combinations.
CPC Classifications
A61K 31/58 A61K 9/1617 A61K 9/1635 A61K 9/1694 A61K 9/2009 A61K 9/2013 A61K 9/2018 A61K 9/2027 A61K 9/2054 A61K 9/28 A61K 31/454 A61K 31/573 A61K 38/25 A61P 13/08 A61P 15/00 A61P 35/00 A61P 35/04
Filing Date
2025-12-11
Application No.
19415909
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.